Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
Clinical trial NCT03655444 · TERMINATED
Trial details
- NCT number
- NCT03655444
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-29
- Primary completion
- 2020-08-24
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.